title: Perioperative use of alpha2-adrenoceptor agonists and the cardiac patient.
abstract: The centrally acting alpha2-adrenoceptor agonists clonidine and dexmedetomidine have been used with success to provide haemodynamic stability for patients undergoing surgery. Particularly in the case of patients with overt or underlying cardiac disease the actions of alpha2-adrenoceptor agonists, which include maintenance of stable systemic blood pressure and low heart rate and a reduction in overall oxygen consumption, can be expected to reduce the risk of procedure-related cardiac events. This expectation has been corroborated in clinical trials with clonidine, dexmedetomidine and mivazerol and meta-analyses; additional large controlled trials would be instructive in establishing a robust estimate of the scale of the benefit. In addition, alpha2-adrenoceptor agonists used as premedication have been shown to substantially reduce anaesthetic requirements among surgical patients, and the use of these agents has been associated with a reduced risk of postoperative delirium, which may be expected to improve considerably the postoperative course for at-risk patients. Dexmedetomidine is the only alpha2-adrenoceptor agonist currently approved for use in the intensive care unit. A distinctive feature of dexmedetomidine in that setting is that in addition to haemodynamic stability it confers a distinctive and advantageous quality of sedation: patients are tranquil but responsive to requests from attending staff. This review examines the pharmacological principles underlying the use of alpha2-adrenoceptor agonists as adjuncts to surgery and clinical experience in that indication.
authors.affiliation: Department of Anaesthesiology and Intensive Care, University of Turku, Turku, Finland.
authors.forename: R
authors.initials: R
authors.lastname: Aantaa
authors.forename: J
authors.initials: J
authors.lastname: Jalonen
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage*; D002320:Cardiovascular Physiological Phenomena / Q000187:drug effects; D003000:Clonidine / Q000008:administration & dosage*; D020927:Dexmedetomidine / Q000008:administration & dosage*; D006331:Heart Diseases / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D019990:Perioperative Care / Q000379:methods*
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D020927:Dexmedetomidine; D003000:Clonidine